Autolus Therapeutics plc (AUTL): Depreciation & Amortization
$8.30M
Year ended 2025-12-31
$8.59M
Trailing 12 months to 2026-06-30
+3.8%
3-year compound annual growth
+8.0%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.30M | +9.8% | 2026-03-27, From 2025-01-01 |
| 2024-12-31 | $7.55M | +15.1% | 2026-03-27, From 2024-01-01 |
| 2023-12-31 | $6.57M | -11.5% | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | $7.42M | -12.2% | 2024-03-21, From 2022-01-01 |
| 2021-12-31 | $8.46M | +49.5% | 2024-03-21, From 2021-01-01 |
| 2020-12-31 | $5.66M | +22.7% | 2023-03-07, From 2020-01-01 |
| 2019-12-31 | $4.61M | n/a | 2022-03-10, From 2019-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Autolus Therapeutics plc (AUTL) | 2025-12-31 | $8.30M | +9.8% |
| Recursion Pharmaceuticals, Inc. (RXRX) | 2025-12-31 | $83.70M | +129.4% |
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | $12.54M | -2.2% |
| Vir Biotechnology, Inc. (VIR) | 2025-12-31 | $11.68M | -19.8% |
| 4D Molecular Therapeutics, Inc. (FDMT) | 2025-12-31 | $4.69M | +0.9% |
| Champions Oncology, Inc. (CSBR) | 2026-04-30 | $1.38M | -16.0% |
| Sutro Biopharma, Inc. (STRO) | 2025-12-31 | $7.32M | +1.5% |
| ImmunityBio, Inc. (IBRX) | 2025-12-31 | $15.53M | -11.6% |
| Agenus Inc (AGEN) | 2025-12-31 | $10.00M | -25.1% |
Compare AUTL, RXRX, MGTX, VIR side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗